Tender detail

Intravenous human plasma-derived immunoglobulin medicine

Summary

Healthcare Public Procurement (HeCaPP) is procuring a pharmaceutical product containing immunoglobulins derived from human plasma for intravenous administration. The single lot covers supply to participating hospitals in Brussels and Woluwe-Saint-Lambert for a planned period of 48 months.

Reference number
797524-2026
Buyer
Healthcare Public Procurement (HeCaPP)
Country
Belgium (BEL)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2026-11-23
Status
Open
Contract subject
Supplies
Estimated value
Not published
Source
TED

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.